Perspective Therapeutics Inc (CATX)
R&D Expense Growth
6.41%
Quarterly · Period ending:
CATX R&D Expense Growth
Latest reported6.41%period ending
Latest reported6.41%period ending
CATX Quarterly R&D Growth (QoQ) (0.00% → 6.41%)
Latest values, visible window
High-resolution chart · PNG
CATX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |